NCBI Summary
The protein encoded by this gene is the beta component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Fibrinogen serves key roles in hemostasis and antimicrobial host defense. Mutations in this gene lead to several disorders, including afibrinogenemia, dysfibrinogenemia, hypodysfibrinogenemia and thrombotic tendency. [provided by RefSeq, Aug 2020].
Protein
Protein (NP_005132)
Fibrinogen beta chain
Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain]
FGB
fibrinogen beta chain
Undefined
Very low evidence
Ficolin-like
Undefined
a/b mixed with b-sheet / Fibrinogen C-ter like
MKRMVSWSFHKLKTMKHLLLLLLCVFLVKSQGVNDNEEGFFSARGHRPLDKKREEAPSLRPAPPPISGGGYRARPAKAAATQKKVERKAPDAGGCLHADPDLGVLCPTGCQLQEALLQQERPIRNSVDELNNNVEAVSQTSSSSFQYMYLLKDLWQKRQKQVKDNENVVNEYSSELEKHQLYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFFPQQ
Mol* PDB structure viewerUniLectin3D
Ligand
Glycan ligands from structural data
No crystal structures of complexes with glycan ligand.
References
NCBI References (10 PubMed Identifiers)
- Identification of a novel mutation in congenital afibrinogenemia in Iranian patients. [33901106]
- Identification and characterization of novel mutations in Chinese patients with congenital fibrinogen disorders. [32877852]
- A Novel Amino Acid Substitution, Fibrinogen Bbetap.Pro234Leu, Associated with Hypofibrinogenemia Causing Impairment of Fibrinogen Assembly and Secretion. [33322044]
- Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype. [32610551]
- Antimicrobial activity of fibrinogen and fibrinogen-derived peptides--a novel link between coagulation and innate immunity. [23467586]
- Fibrinogen and fibrin. [6383194]
- Characterization of complementary deoxyribonucleic acid and genomic deoxyribonucleic acid for the beta chain of human fibrinogen. [6688356]
- [Temperature-dependent changes in the profile of the sarcoplasmic reticulum membrane hydrophobic zones]. [156564]
- Amino acid sequence of the beta chain of human fibrinogen. [420779]
- Primary structure of human fibrinogen. Characterization of disulfide-containing cyanogen-bromide fragments. [891553]
UniProt Main References (29 PubMed Identifiers)
- Nucleotide sequences of the three genes coding for human fibrinogen. [2102623]
- Complete sequencing and characterization of 21,243 full-length human cDNAs. [14702039]
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). [15489334]
- Cloning of fibrinogen genes and their cDNA. [6575700]
- Characterization of the 5'-flanking region for the human fibrinogen beta gene. [3029722]
- Disulfide bridges in nh2 -terminal part of human fibrinogen. [936108]
- Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. [12665801]
- Covalent structure of fibrinogen. [6575689]
- The interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosis. [7642629]
- Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. [16335952] Show more
All isoforms of this gene containing a lectin domain
RNA
RNA (Transcript ID: NM_005141.5)
fibrinogen beta chain, transcript variant 1
m7G-5')ppp(5'-AAGUCUACAUGAAAAGGAUGGUUUCUUGGAGCUUCCACAAACUUAAAACCAUGAAACAUCUAUUAUUGCUACUAUUGUGUGUUUUUCUAGUUAAGUCCCAAGGUGUCAACGACAAUGAGGAGGGUUUCUUCAGUGCCCGUGGUCAUCGACCCCUUGACAAGAAGAGAGAAGAGGCUCCCAGCCUGAGGCCUGCCCCACCGCCCAUCAGUGGAGGUGGCUAUCGGGCUCGUCCAGCCAAAGCAGCUGCCACUCAAAAGAAAGUAGAAAGAAAAGCCCCUGAUGCUGGAGGCUGUCUUCACGCUGACCCAGACCUGGGGGUGUUGUGUCCUACAGGAUGUCAGUUGCAAGAGGCUUUGCUACAACAGGAAAGGCCAAUCAGAAAUAGUGUUGAUGAGUUAAAUAACAAUGUGGAAGCUGUUUCCCAGACCUCCUCUUCUUCCUUUCAGUACAUGUAUUUGCUGAAAGACCUGUGGCAAAAGAGGCAGAAGCAAGUAAAAGAUAAUGAAAAUGUAGUCAAUGAGUACUCCUCAGAACUGGAAAAGCACCAAUUAUAUAUAGAUGAGACUGUGAAUAGCAAUAUCCCAACUAACCUUCGUGUGCUUCGUUCAAUCCUGGAAAACCUGAGAAGCAAAAUACAAAAGUUAGAAUCUGAUGUCUCAGCUCAAAUGGAAUAUUGUCGCACCCCAUGCACUGUCAGUUGCAAUAUUCCUGUGGUGUCUGGCAAAGAAUGUGAGGAAAUUAUCAGGAAAGGAGGUGAAACAUCUGAAAUGUAUCUCAUUCAACCUGACAGUUCUGUCAAACCGUAUAGAGUAUACUGUGACAUGAAUACAGAAAAUGGAGGAUGGACAGUGAUUCAGAACCGUCAAGACGGUAGUGUUGACUUUGGCAGGAAAUGGGAUCCAUAUAAACAGGGAUUUGGAAAUGUUGCAACCAACACAGAUGGGAAGAAUUACUGUGGCCUACCAGGUGAAUAUUGGCUUGGAAAUGAUAAAAUUAGCCAGCUUACCAGGAUGGGACCCACAGAACUUUUGAUAGAAAUGGAGGACUGGAAAGGAGACAAAGUAAAGGCUCACUAUGGAGGAUUCACUGUACAGAAUGAAGCCAACAAAUACCAGAUCUCAGUGAACAAAUACAGAGGAACAGCCGGUAAUGCCCUCAUGGAUGGAGCAUCUCAGCUGAUGGGAGAAAACAGGACCAUGACCAUUCACAACGGCAUGUUCUUCAGCACGUAUGACAGAGACAAUGACGGCUGGUUAACAUCAGAUCCCAGAAAACAGUGUUCUAAAGAAGACGGUGGUGGAUGGUGGUAUAAUAGAUGUCAUGCAGCCAAUCCAAACGGCAGAUACUACUGGGGUGGACAGUACACCUGGGACAUGGCAAAGCAUGGCACAGAUGAUGGUGUAGUAUGGAUGAAUUGGAAGGGGUCAUGGUACUCAAUGAGGAAGAUGAGUAUGAAGAUCAGGCCCUUCUUCCCACAGCAAUAGUCCCCAAUACGUAGAUUUUUGCUCUUCUGUAUGUGACAACAUUUUUGUACAUUAUGUUAUUGGAAUUUUCUUUCAUACAUUAUAUUCCUCUAAAACUCUCAAGCAGACGUGAGUGUGACUUUUUGAAAAAAGUAUAGGAUAAAUUACAUUAAAAUAGCACAUGAUUUUCUUUUGUUUUCUUCAUUUCUCUUGCUCACCAAGAAGUAACAAAAGUAUAGUUUUGACAGAGUUGGUGUUCAUAAUUUCAGUUCUAGUUGAUUGCGAGAAUUUUCAAAUAAGGAAGAGGGGUCUUUUAUCCUUGUCGUAGGAAAACCAUGACGGAAAGGAAAAACUGAUGUUUAAAAGUCCACUUUUAAAACUAUAUUUAUUUAUGUAGGAUCUGUCAAAGAAAACUUCCAAAAAGAUUUAUUAAUUAAACCAGACUCUGUUGCAAUAAGUUAAUGUUUUCUUGUUUUGUAAUCCACACAUUCAAUGAGUUAGGCUUUGCACUUGUAAGGAAGGAGAAGCGUUCACAACCUCAAAUAGCUAAUAAACCGGUCUUGAAUAUUUGAAGAUUUAAAAUCUGACUCUAGGACGGGCACGGUGGCUCACGACUAUAAUCCCAACACUUUGGGAGGCUGAGGCGGGCGGUCACAAGGUCAGGAGUUCAAGACCAGCCUGACCAAUAUGGUGAAACCCCAUCUCUACUAAAAAUACAAAAAUUAGCCAGGCGUGGUGGCAGGUGCCUGUAGUCCCAGCUACCUGUGAGGUGGAGAUUGCAUUGAGCCAAGAUCUCAACACUGCACUCCAGCCUGGGCAACAGCGUGAGACUCCACCUCAAAAAAAAAAAAAAAAGAAUCUGACUAUAUACCAUGGAAAAGCCACCACUCUGCCACUUAAAUAAACAUCAGGAUCAGAGAUUCCAAGAGGACAAUCUGCAUCAAGUCUUCACCAAGUGUUUUUUAAGCGAAAUAAUGAAAUAGGGAGCAGAAUAUGCCUGUUGCCCAUAGAAACGAGGUCUAUUCUUGUCCUCAAUUAGGCUUUUUUUUCUUCAUAGUUACACCAGAACUAAAGUAAAAGUGGUUUUUCUGUUCUUUCUACUUCUCCCCAUGAAAUGGGCAUAUCAUCUCAACACUUCACUCCAAGUCGCCACGGGCAACCUUAUGACCCUAGGUCCUCCACCCCUAAUGUAUCAUCAUUGCCACCCAUUUUUAUGGUACUUAUUGUUCUUAAGCUUAUCCUCUUAAUCUUUUCAUGUAAGCAAAGCUCAUUAAUUUCUGUCUUGGAAAUGCUACUACUCUCUUUAAUUACUCACCAAAUCCAACUUUAACUUUUGACCUGGUUUCUCUGCCACAAGUUCUGUCCCACUGGAGCCCAUACUCACCUACCGCUUUGCCAUCACAUUUAACAGAAAACUCUUAUCAACUUACUUCCUGCUUAACAUUAGCUCCUUCCUAUCUAUAUCCAAAUUUCUUAAAUUCAAAUUUUUUAGCUGGAGUAAAAAUGGUCCCAGUACCAUUUCCUGUUCCCUUCACUAUAACCUACAUUUUUGUCACAUUAAGUUUUUCCCCAUUCCAGGACAGGUCAGGCCCUUUAAAAAUUUCAACAGCUUUAUUGAGAUAUAAUUGAUAUAAUUUAAAAAAUCCUGCACAUGUGUCAUGCUGGAGCCCUAUUGAUUCCAACAGGGAUGGCGCCUUGUCCAAGAAGAGACCCAGAGCCAGUGAAUGGGACAUAGGGUUUAUUUAGGACUUAAAUACAGAUGUGGUCCAGUGGCAGUGGGCUGGACAGGACCGCUACUAUUUGUAAAGAGUAUGUAGUUUAUAUAACAUUUCUACUUAGCACUCUCCACUUAGCAACCUCCAUUUAACCCAAAAUAAAAGGCCUUGGUUCCUUGCACAUCCUGAGUUCCAACGGACAGGCAGGGAGUUCAAGUGUCCUUCACAGAUAAGAAGUGAAUCUCUCUGGGUUGGCCAUUCCCGGAUUCCUUAGCUUAGACUCUGAACACAUAUUCUUCUUAGACCAUACAGUCAUUCUCAGGGUAUGCUUGAGUUAAUGCUGUCGGAUGCAUCUGUCAUACAAAGUGUUUAACAUAUACGAUUUCAUGAUUUUGGAAAUAUGCAUACACCCAUGAUAUCACUGGCACAGUCAAGAUAUUAAAUAUAUCCAUCACCUCCAAAA-3'- Poly-A tail
- Coding region
DNA
DNA (Gene ID: 2244)
fibrinogen beta chain
strand +
NCBI CDS gene sequence (1476 bp)
5'-ATGAAAAGGATGGTTTCTTGGAGCTTCCACAAACTTAAAACCATGAAACATCTATTATTGCTACTATTGTGTGTTTTTCTAGTTAAGTCCCAAGGTGTCAACGACAATGAGGAGGGTTTCTTCAGTGCCCGTGGTCATCGACCCCTTGACAAGAAGAGAGAAGAGGCTCCCAGCCTGAGGCCTGCCCCACCGCCCATCAGTGGAGGTGGCTATCGGGCTCGTCCAGCCAAAGCAGCTGCCACTCAAAAGAAAGTAGAAAGAAAAGCCCCTGATGCTGGAGGCTGTCTTCACGCTGACCCAGACCTGGGGGTGTTGTGTCCTACAGGATGTCAGTTGCAAGAGGCTTTGCTACAACAGGAAAGGCCAATCAGAAATAGTGTTGATGAGTTAAATAACAATGTGGAAGCTGTTTCCCAGACCTCCTCTTCTTCCTTTCAGTACATGTATTTGCTGAAAGACCTGTGGCAAAAGAGGCAGAAGCAAGTAAAAGATAATGAAAATGTAGTCAATGAGTACTCCTCAGAACTGGAAAAGCACCAATTATATATAGATGAGACTGTGAATAGCAATATCCCAACTAACCTTCGTGTGCTTCGTTCAATCCTGGAAAACCTGAGAAGCAAAATACAAAAGTTAGAATCTGATGTCTCAGCTCAAATGGAATATTGTCGCACCCCATGCACTGTCAGTTGCAATATTCCTGTGGTGTCTGGCAAAGAATGTGAGGAAATTATCAGGAAAGGAGGTGAAACATCTGAAATGTATCTCATTCAACCTGACAGTTCTGTCAAACCGTATAGAGTATACTGTGACATGAATACAGAAAATGGAGGATGGACAGTGATTCAGAACCGTCAAGACGGTAGTGTTGACTTTGGCAGGAAATGGGATCCATATAAACAGGGATTTGGAAATGTTGCAACCAACACAGATGGGAAGAATTACTGTGGCCTACCAGGTGAATATTGGCTTGGAAATGATAAAATTAGCCAGCTTACCAGGATGGGACCCACAGAACTTTTGATAGAAATGGAGGACTGGAAAGGAGACAAAGTAAAGGCTCACTATGGAGGATTCACTGTACAGAATGAAGCCAACAAATACCAGATCTCAGTGAACAAATACAGAGGAACAGCCGGTAATGCCCTCATGGATGGAGCATCTCAGCTGATGGGAGAAAACAGGACCATGACCATTCACAACGGCATGTTCTTCAGCACGTATGACAGAGACAATGACGGCTGGTTAACATCAGATCCCAGAAAACAGTGTTCTAAAGAAGACGGTGGTGGATGGTGGTATAATAGATGTCATGCAGCCAATCCAAACGGCAGATACTACTGGGGTGGACAGTACACCTGGGACATGGCAAAGCATGGCACAGATGATGGTGTAGTATGGATGAATTGGAAGGGGTCATGGTACTCAATGAGGAAGATGAGTATGAAGATCAGGCCCTTCTTCCCACAGCAATAG-3'
By using this site you agree to our privacy policy.
Please confirm you agree with the privacy policy before using the site.